ConvaTec Group’s (CTEC) “Overweight” Rating Reiterated at JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their overweight rating on shares of ConvaTec Group (LON:CTEC) in a report issued on Friday, MarketBeat.com reports.

A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research report on Wednesday, July 30th. Peel Hunt reaffirmed an “add” rating and issued a GBX 270 price objective on shares of ConvaTec Group in a report on Thursday. Berenberg Bank reduced their price objective on shares of ConvaTec Group from GBX 335 to GBX 330 and set a “buy” rating for the company in a research note on Tuesday, August 19th. UBS Group reissued a “buy” rating and set a GBX 375 target price on shares of ConvaTec Group in a report on Friday, November 7th. Finally, Royal Bank Of Canada raised ConvaTec Group to an “outperform” rating and cut their price target for the stock from GBX 320 to GBX 315 in a report on Thursday, August 21st. Six equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of GBX 318.67.

ConvaTec Group Price Performance

Shares of LON CTEC opened at GBX 247.60 on Friday. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. The stock has a fifty day simple moving average of GBX 238.53 and a two-hundred day simple moving average of GBX 252.22. ConvaTec Group has a 1-year low of GBX 218 and a 1-year high of GBX 311.20. The firm has a market cap of £4.91 billion, a price-to-earnings ratio of 23.36, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64.

Insider Activity

In other ConvaTec Group news, insider Jonny Mason purchased 50,000 shares of the company’s stock in a transaction dated Thursday, August 28th. The stock was purchased at an average price of GBX 235 per share, for a total transaction of £117,500. Company insiders own 0.94% of the company’s stock.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.